🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07828119
Starting soon Not applicable

The Effect of a Hybrid Approach in Breast Cancer Education on Women's Awareness, Fatalism, and Self-Compassion Levels: A Randomized Controlled Trial

NCT07828119 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-09-15
Last updated
2026-09-18

Condition(s) studied

Breast Cancer Awareness

Investigational drug(s) / intervention(s)

Hybrid Breast Cancer Education

Hybrid Breast Cancer Education: The experimental group will receive a hybrid breast cancer education model consisting of a face-to-face training session using a breast model, followed by educational materials, informative messages, and reminders delivered via a mobile application over a four-week period

Study summary

This randomized controlled trial aims to evaluate the effect of a hybrid breast cancer education program on women's breast cancer awareness, cancer fatalism, and self-compassion levels. The study will include 128 women aged 20-65 who apply to an obstetrics and gynecology outpatient clinic. Participants will be randomly assigned to either an experimental group or a control group. The experimental group will receive a hybrid education model. This model consists of a face-to-face training session using a breast model, followed by four weeks of educational materials, informative messages, and reminders delivered via a mobile application. The control group will receive routine healthcare services without this specific educational intervention. Researchers will measure the participants' levels of self-compassion, breast cancer fatalism, and breast cancer awareness using standardized questionnaires. These measurements will be taken at the beginning of the study (pre-test) and four weeks later (post-test) to determine if the technology-supported hybrid education model is effective in improving early diagnosis awareness and psychosocial outcomes

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being between 20 and 65 years of age * Being female * Agreeing to participate in the study and signing the informed consent form * Having no prior diagnosis of breast cancer * Having the ability to use a mobile application Exclusion Criteria: * Having a prior diagnosis of breast cancer or active breast pathology * Having any cognitive, mental, or communication barrier that prevents participation in training * Refusing to participate or withdraw consent during the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kahramanmaras Sutcu Imam University Hospital, Department of Obstetrics and Gynecology, Delivery Room Kahramanmaraş Merkez

More Kahramanmaras Sutcu Imam University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07828119 on ClinicalTrials.gov ↗ ← All trials in Turkey